Skip to main content
Veterinary Medicines

Bupaq Multidose 0,3mg/ml Injektionslösung für Hunde und Katzen

Authorised
  • Buprenorphine hydrochloride

Product identification

Medicine name:
Bupaq Multidose 0,3mg/ml Injektionslösung für Hunde und Katzen
Bupaq Multidose vet 0,3 mg/ml injektioneste, liuos
Active substance:
  • Buprenorphine hydrochloride
Target species:
  • Dog
  • Cat
Route of administration:
  • Intramuscular use
  • Intravenous use

Product details

Active substance and strength:
  • Buprenorphine hydrochloride
    0.32
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Dog
    • Cat
  • Intravenous use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN02AE01
Authorisation status:
  • Valid
Authorised in:
  • Finland
Package description:
  • Amber glass vials type I, bromobutyl rubber stopper type I, coated, aluminium cap Package size: 10 ml
  • Amber glass vials type I, bromobutyl rubber stopper type I, coated, aluminium cap Package size: 10 x 10 ml
  • Amber glass vials type I, bromobutyl rubber stopper type I, coated, aluminium cap Package size: 5 x 10 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Richter Pharma AG
Marketing authorisation date:
This information is not available for this product.
Manufacturing sites for batch release:
  • Vetviva Richter GmbH
Responsible authority:
  • Finnish Medicines Agency
Authorisation number:
  • 29188
Date of authorisation status change:
Reference member state:
  • Austria
Procedure number:
  • AT/V/0008/001
Concerned member states:
  • Belgium
  • Bulgaria
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."